03.09.10
Institut Rosell-Lallemand has acqui of LAFTI for dietary supplements business from DSM Food Specialties. LAFTI is a range of probiotic strains with targeted health benefits, supported by strong scientific and clinical evidence. For Institut Rosell-Lallemand, LAFTI represents an excellent asset to its existing portfolio of probiotics targeting specific health segments such as gut health, immunology, women’s and children’s health. DSM Food Specialties retains the dairy portion of LAFTI business through a license agreement, reflecting the company’s strategy to concentrate on food and beverage probiotic applications. The LAFTI range comprises three strains: Lactobacillus acidophilus LAFTI L10, Lactobacillus casei LAFTI L26 and Bifidobacterium animalis lactis LAFTI B94.